Correction [0.03%]
改正错误
Published Erratum
Cancer biology & therapy. 2025 Dec 31;27(1):2602376. DOI:10.1080/15384047.2025.2602376 2025
RVd and CyBorD therapies remodel B-cell maturation signaling and alter immune and clonal architecture in multiple myeloma [0.03%]
来那度胺联合疗法重塑多发性骨髓瘤中成熟信号及免疫和克隆结构
Zuzana Valuskova,Dana Cholujova,Gabor Beke et al.
Zuzana Valuskova et al.
Background: Multiple myeloma (MM) features plasma cell (PC) heterogeneity and alterations in B-cell differentiation and immune regulation. Although lenalidomide/bortezomib/dexamethasone (RVd) and cyclophosphamide/bortezom...
Validation of the important role and prognostic value of KIF14 in triple-negative breast cancer [0.03%]
验证KIF14在三阴性乳腺癌中重要作用及其预后价值的真实性
Jingjing Yuan,Meilin Zhang,Yaxuan Liu et al.
Jingjing Yuan et al.
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with a poor prognosis and limited treatment options. Elevated Kinesin Family Member 14 (KIF14) expression in breast cancer (BC) is correlated with ...
Protein lactylation: molecular mechanisms underlying lactate-driven tumorigenesis and cancer progression [0.03%]
蛋白质乳酸化：驱动肿瘤发生和发展的乳酸分子机制
Qianyun Xie,Lijuan Weng,Yuqing Hu et al.
Qianyun Xie et al.
Lactylation, a recently identified post-translational modification, has reshaped our understanding of lactate from a metabolic byproduct to a central regulator of tumor biology. Accumulating evidence reveals that lactate-driven lactylation ...
Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation [0.03%]
靶向MSLN的癌症治疗新视角：从分子机制到临床转化
Zhendong Wu,Xuefei Fu,Yuan Feng et al.
Zhendong Wu et al.
Mesothelin (MSLN) is a glycosylphosphatidylinositol (GPI)-anchored membrane protein that promotes malignant behaviors including tumor cell proliferation, migration and immune evasion through activation of multiple signaling pathways, such a...
YTHDF2 enhances proliferation and metastasis of nasopharyngeal carcinoma by mediating m6A modification in destabilizing FOXO1 mRNA [0.03%]
YTHDF2通过介导不稳定FOXO1 mRNA的m６A修饰促进鼻咽癌增殖和转移
Peng Yu,Wenyang Wei,Xinyun Peng et al.
Peng Yu et al.
Background: Aberrant N6-methyladenosine (m6A) modification is linked to cancer development and progression. However, the role of YTH N6-methyladenosine RNA binding protein F2 (YTHDF2), an m6A 'reader protein', in nasophar...
GNAQ inhibits tumorigenesis via the ARHGEF25-mediated RHOA pathway in NK/T-cell lymphoma [0.03%]
GNQA通过ARHGEF25介导的RHOA通路抑制NK/T细胞淋巴瘤的发生发展
Yuyang Gao,Zihe Zhang,Yue Song et al.
Yuyang Gao et al.
Background: Natural killer/T-cell lymphoma (NKTCL) presents highly aggressive clinical behaviour, and the outcomes for relapsed and refractory patients are still poor. Our previous study identified somatic mutations in GN...
Nuclear translocation of Cx43 promotes to CRC progression and associates with β-catenin accumulation [0.03%]
Cx43核转位促进结直肠癌进展并伴随β-连环蛋白积累
Shuo Wang,Ziling Zhu,Yin Zhu et al.
Shuo Wang et al.
Background: The tumour microenvironment (TME) significantly influences intercellular communication, with several secreted factors activating both tumour cells and fibroblasts. Connexin43 (Cx43), a crucial gap junction pro...
A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer [0.03%]
一种基于生物芯片的液体活检技术用于检测前列腺癌细胞外囊泡RNA
Yanjun Diao,Ani Nan,Rui Li et al.
Yanjun Diao et al.
Background: Prostate cancer (PCa) is a major health concern, and current PSA screening is limited by low specificity and the risk of overdiagnosis. Extracellular vesicle (EV)-derived RNA biomarkers offer a promising non-i...
Toll-like receptor 4 inhibition sensitizes non-small cell lung cancer to radiotherapy [0.03%]
toll-like受体4抑制使非小细胞肺癌敏感化以接受放射治疗
Ryma Haroun,Cleopatra Rutihinda,Aissatou Hadja Diallo et al.
Ryma Haroun et al.
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Although radiotherapy (RT) is used to treat over half of NSCLC patients, about 30% have inherent or acquired radioresistance leading to treatment...